Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension

Diabetes Care

Volumn 30, Issue 6, 2007, Pages 1605-1607

  Kwang, Kon Koh ^a   Quon, Michael J ^b   Sang, Jin Lee ^a   Seung, Hwan Han ^a   Jeong, Yeal Ahn ^a   Kim, Jeong A ^b   Chung, Wook Jin ^a   Lee, Yonghee ^c   Eak, Kyun Shin ^a  

^a Gachon University College of Medicine   (South Korea)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; EFONIDIPINE; INSULIN; LEPTIN; MALONALDEHYDE; PLACEBO; RESISTIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FACE; FEMALE; FLUSHING; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN BLOOD LEVEL; MALE; METABOLIC PARAMETERS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADIPONECTIN; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHOLESTEROL, HDL; DIHYDROPYRIDINES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; LEPTIN; NITROPHENOLS; ORGANOPHOSPHORUS COMPOUNDS; PLACEBOS; VASODILATION;

EID: 34249893067     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2267     Document Type: Article

References (19)

1. Kim J, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888-1904, 2006
2. Garcia-Puig J, Ruilope LM, Luque M, Fernandez J, Ortega R, Dal-Re R, AVANT Study Group Investigators: Glucose metabolism in patients with essential hypertension. Am J Med 119:318-326, 2006
3. Taylor EN, Hu FB, Curhan GC: Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care 29:1065-1070, 2006
4. Asano Y, Kim J, Ogai A, Takashima S, Shintani Y, Minamino T, Kitamura S, Tomoike H, Hori M, Kitakaze M: A calcium channel blocker activates both ecto-5(′)-nucleotidase and NO synthase in HUVEC. Biochem Biophys Res Commun 311:625-628, 2003
5. Han SH, Quon MJ, Kim JA, Koh KK: Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 49:531-538, 2007
6. Correia ML, Haynes WG: Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 13:215-223, 2004
7. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:736-740, 2003
8. Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T: Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo. J Hypertens 19:2031-2037, 2001
9. Oshima T, Ozono R, Yano Y, Higashi Y, Teragawa H, Miho N, Ishida T, Ishida M, Yoshizumi M, Kambe M: Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension. Hypertens Res 28:889-894, 2005
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21 (Suppl. 1):S5-S22, 1998
11. Koh KK, Quon MJ, Han SH, Ahn JY, Jin DK, Kim HS, Kim DS, Shin EK: Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. Hypertension 45:1088-1093, 2005
12. Koh KK, Quon MJ, Han SH, Chung W-J, Lee Y, Shin EK: Anti-inflammatory and metabolic effects of candesartan in hypertensive patients. Int J Cardiol 108:96-100, 2006
13. Koh KK, Quon MJ, Han SH, Chung W-J, Ahn JY, Kim J, Kang WC, Lee Y, Shin EK: Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic, hypertensive patients. Diabetes Care 29:195-201, 2006
14. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410, 2000
15. Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, Kim HS, Shin MS, Ahn TH, Choi IS, Shin EK: Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Coll Cardiol 42:905-910, 2003
16. Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant Tand L-type Ca channels with distinct inhibitory mechanisms. Pharmacology 78:11-20, 2006
17. Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Murakami K, Higaki J: The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. Clin Ther 28:1677-1685, 2006
18. Koh KK, Han SH, Quon MJ: Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 46:1978-1985, 2005
19. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026, 2003